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Abstract 
There are informal and formal markets for medicinal plants’ products in Nigeria. The formal market is subject to the 
national regulatory framework for Food and Drug Administration and Control. It is relatively new and underdeveloped.  This 
study was designed to appraise this market with special emphasis on the market participants, market structure, marketing 
functions performed, conduct of sellers in the market and; standards and regulations to which the market is subject. Information 
used for this study was collected through personal interviews and interactions with key participants in the market; especially the 
officials of regulatory agency. The market structure was analysed in terms of the share of market controlled by participants and 
product types. Concentration Ratios (CR2 and CR4) were used to assess the market share. Marketing functions being performed 
were described in terms of the exchange, physical and facilitating functions while the conduct was described in terms of pricing 
and promotional strategies. The regulatory framework under which the market operates was appraised. The market was highly 
concentrated with a CR2 and CR4 of 58.5% and 80.8 %; respectively. Imported products accounted for only 12.3% of the market. 
The predominant modes of presentation of the product were capsule (41.6%) and liquid (36.2%). About 20.77% of the products 
were classified as multivitamins, 13.85% were antibiotics while 10.77% addressed sexual dysfunctional problems. These products 
were regulated under the Food and Drug Administration and Control (NAFDAC) decrees, 1993-1999. Only 2.3% of the products 
have received full registration status while the others were only listed.
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Introduction
Medicinal plants are one of the three main categories of plants that are described as herbs. The other two are flavouring 
and fragrance (Foster, 2006). Medicinal plants and their products are the basis of traditional medicines (Mafimisebi and 
Oguntade, 2010). They are also the starting materials for prescription drugs through compound purification or semi-synthetic 
processes. They also formed the basis of non-prescription (OTC) drugs, phyto-medicines and dietary supplements (Calixto, 2000).  
Herbs that are used for fragrance serve as the basis for the production of essential oils that are used for the enhancement in food, 
drugs, and cosmetics, fragrance materials for the perfume industry and as aromatherapy. Flavouring herbs are packaged and sold 
as spices to final consumers or to manufacturers for technical enhancement of commercial products (Foster, 2006)
The worldwide market for medicinal and aromatic plants, medicinal and vegetable saps and extracts, and vegetable 
alkaloids (pharmaceutical) was valued at about US$8 billion. The market for spices and herbs was valued at US$3 billion while 
that of cosmetics was valued at about US$1.5 billion (Parke and Tikasingh, 2004). Medicinal plants are finding a new, expanding 
market as herbal components of health foods and preventative medicines, especially under the terms functional foods and 
nutraceuticals; and natural health products. They are often processed into a wide range of products including tablets, capsules, 
teas, tinctures, creams, oils, and liquids. The products tend to address the same ailments as over-the counter medications such as 
laxatives, weight-loss remedies, immune system enhancers, anti-aging remedies, and products to relieve anxiety and stress
(Agriculture and Agri-Foods Canada, 2009). Many of these products are simply referred to as herbal medicines. According to 
WHO (1998a, 1998b) herbal medicines are finished, labeled medicinal products that contain as active ingredients, aerial or 
underground part of plants or other plant materials, or combination thereof, whether in the crude state or as plant preparations.
In Nigeria, two distinct markets for medicinal plants’ products could be identified1. These are the (traditional) informal 
and the formal markets. A formal market has a legal regulatory framework within which market transactions are undertaken. On 
the contrary, for an informal market, there exists no specific legal regulatory framework. Operators within informal markets carry 
out their transactions based on norms and practices that have evolved in the markets over the years (Ortiz et.al. 2010).  The 
informal market for medicinal plants and plant products in Nigeria has its roots in traditional medicine and it is widely spread 
across the country. A significant number of Nigerians, especially in rural/agricultural communities, depends on herbal medicines 
                                                          
1 The market, considered from the product’s dimension, refers to a group of consumers or organizations that is 
interested in the product, has the resources to purchase the product and is permitted by law and other regulations to 
acquire the product (Office of Fair Trading, 2004).
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obtained from the informal market for the treatments of various ailments (NBS, 2006; Mafimisebi and Oguntade, 2010). The 
formal market for medicinal plants’ products on the other hand is relatively new and underdeveloped. It is formal because there is 
a legal regulatory framework in place, which provides some guidance to transactions in the market in Nigeria. This study
appraised the formal market for medicinal plants’ products in Nigeria with special emphasis on market participants and structure,
marketing functions being performed, conduct of sellers in the market and; standards and regulations governing the market.
Materials and methods
The information used for this study was collected through personal interviews and interactions with key participants in 
the formal market for medicinal plants’ products in Nigeria; especially the marketers of medicinal plants’ products and officials of 
National Agency for Food and Drug Administration and Control (NAFDAC)2.  Some official documents of the Agency were also 
consulted. 
The market structure was analyzed in terms of the share of market controlled by participants and product types. 
Concentration Ratios (CR2 and CR4) were used to assess the level of concentration in the market. The marketing functions being 
performed by the participants in the market were described in terms of exchange, physical and facilitating functions being 
performed while the conduct was described in terms of pricing and promotional strategies. The regulatory framework, which 
defines the market as formal, was appraised. 
The Concentration Ratios (CR2 and CR4) are the shares of the market being controlled by the two and four largest firms 
in the market. The share in this case was defined with respect to the number of products approved by the regulatory agency that 
are in the market.  The higher the share controlled by a few firms, the more concentrated is the market.
Results
Market structure 
Seven major participants in the formal market for the medicinal plants’ products in Nigeria could be identified. These 
were the ‘traditional medicine memory bank’ (Okunlola, 2007), researchers (Odugbemi, 2007), entrepreneurs/producers, 
advertising agencies/media organizations, retailers, regulators (the most important being NAFDAC) and the consumers. These 
participants performed various functions and were active to various degrees.  
It was difficult to establish a reasonable value for the market for medicinal plants’ products. The market was relatively 
young and small in size. The survey yielded a total of 130 products that have been registered by NAFDAC. There were two 
distinct categories of suppliers in the market; namely; the local producers and distributors of imported products. Imported 
products accounted for 12.3 % of the medicinal plants’ products while local products accounted for the remaining 87.7% (Table 
1). 
The market was highly concentrated in terms of share of the market captured by marketers.  Two firms accounted for 
58.5% of the products being offered while four firms accounted for 80.8% of the products. Thirteen firms accounted for the 
remaining 12.3% or 16 products (Table 1). 
The predominant mode of presentation of the products was capsule, which accounted for 41.6% of the products. This 
was followed by liquid, which accounted for 36.2% (Table 1). 
About 97.7% of the products were given the status of “Listing” by NAFDAC while only 2.3% enjoys full registration (Table 1). A 
product is given the status of “Listing” by NAFDAC if the latter has subjected it to laboratory analysis to ascertain the chemical 
composition and non-toxicity of the chemical components but has not been subjected to clinical trials.  The registration of a listed 
product is to be renewed every two years while for a product given full registration, renewal with NAFDAC is every five years.
Table 2 presents the distribution of the products based on the health issues addressed. About 20.77% of the products 
were classified as multivitamins, 13.85% were antibiotics while 10.77% addressed sexual dysfunctional problems.
Marketing functions performed
The marketing functions being performed by the participants in the market could be categorized into exchange, physical 
and facilitating functions (Crawford, 1997; Kohls and Uhl, 1990). Central to the market was the exchange function, i.e. buying 
and selling of medicinal plants’ products while the physical and the facilitating functions ensured that the medicinal plants’ 
products were available in the market.  The entrepreneurs in the market processed medicinal plants into acceptable forms and 
distributed them across the market.  The acceptable forms adopted include infusions, capsules, tablets, etc. (see Table 1). These 
are the critical physical functions that made the existence of the formal medicinal plants’ products market possible.  
The critical facilitating functions in the market were standardization, financing and risk bearing. The financing and risk 
bearing functions were being performed by the entrepreneurs while standardization in the market was ensured essentially by 
the regulatory activities of NAFDAC. The Advertising Practitioners Council of Nigeria regulates the conduct of its members thus 
                                                          
2 NAFDAC is the regulatory agency for foods and drugs in Nigeria
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indirectly influencing the way medicinal plants’ products were being advertised. NAFDAC also had regulations governing the 
advertisement of regulated products.
Conduct in the market
The formal market for medicinal plants’ products was experiencing aggressive pricing and promotional strategies. Tie 
in sales was common.  Some of the brands’ were tying medical consultation and sales of products together.  Brand promotion was 
intense especially among new entrants.  The brand name was used to sell a family of products.  The electronic media were the 
media of choice. Rather than operating through pharmacy shops and patent medicine outlets, medicinal plants’ products made in 
Nigeria were mostly distributed through special outlets, which were aggressively advertised.
Table 1: Structure of the medicinal plants’ products’ market 
Market structure Frequency Percent
Imported 16 12.3
Local 114 87.7
Product origin Total 130 100
CR2 58.5







Tea bag 2 1.5
Mode of presentation Total 130 100
Listing 127 97.7
Registered 3 2.3
Type of registration Total 130 100
Source: Authors’ computation from market survey data
The distributors of imported medicinal plants’ products used the electronic media less aggressively as their local counterparts. 
Their products were sometimes distributed through pharmacy shops and patent medicine outlets and through a chain of 
distributors and retailers within special incentive (bonuses) based schemes. The promotional messages were usually designed to
present the products as natural and hence more beneficial to people.  The products were also mostly offered as alternative 
medicine products.
Standards and regulations governing the market
The National Agency for Food and Drug Administration and Control (NAFDAC) Decrees (NAFDAC, 1993 – 1999) 
vests the power to set standards and regulate the manufacture, import and distribution of regulated foods and drugs in NAFDAC.  
The Decree states that the Agency shall, among others, regulate and control the importation, exportation, manufacture, 
advertisement, distribution, sale and use of food, drugs, cosmetics, medical devices, bottled water and chemicals; and conduct 
appropriate tests and ensure compliance with standard specifications approved by the Council for the effective control of the 
quality of foods, drugs, cosmetics, medical devices, bottled water and chemicals and their raw materials as well as their 
production processes in factories and other establishments. Thus from the subsisting NAFDAC decrees, local production, 
importation, exportation, manufacture, advertisement, distribution, sale and use of medicinal plants’ products are subject to 
NAFDAC standards and regulations. NAFDAC regulations generally cover registration of manufacturers and products; and 
labeling and advertisement of products.
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Registration of manufacturers and products
The regulations in respect of registration of manufacturers state, among others, that an application for the registration of 
a regulated product shall be made by the manufacturer. If the manufacturer resides outside Nigeria, it shall be represented in 
Nigeria by a duly registered company or individual with facilities to effect recall of the product when necessary. An applicant for 
a manufacturer outside Nigeria must file evidence of Power of Attorney from the manufacturer which authorizes him to represent 
the manufacturer on all matters relating to the latter’s specialties. The original Power of Attorney is to be notarized and submitted 
to NAFDAC. The manufacturer, in case of imported products, must show evidence that the company is licensed to manufacture 
the regulated product for sale in the country of origin. Such evidence must be prepared by the competent health authority of the 
country of manufacture and shall be authenticated by the Nigerian Mission in that country.
The regulations in respect of regulated products state, among others, that a food, cosmetic, medical device or bottled 
water product (regulated products) shall not be manufactured in Nigeria, unless the factory has been inspected and a certificate of 
recognition issued by NAFDAC. In the case of imported products, there must be evidences of registration of such products by the 
competent health authority of the country of manufacture i.e. products’ licenses/certificates of registration. The evidences must 
indicate that the sale of the products does not constitute a contravention of the Food/Cosmetic/Medical Devices laws of that 
country. In the case of an imported new product, there must be evidence that such product is registered in the country of origin 
and the ingredients are approved raw materials. An applicant shall not be allowed to register a product in more than one brand 
name, except in cases where the manufacturers are different thus having different brand names for the same formulation.
A product is registered with a status of “Listing” by NAFDAC if the agency has subjected it only to laboratory analysis to 
ascertain the chemical composition and non-toxicity of the chemical components. To give full registration, NAFDAC must have 
subjected the product to laboratory analysis and clinical trials.  The registration of a product with a status of “Listing” is to be 
renewed every two years while for a product with full registration; its registration must be renewed with NAFDAC every five 
years.
Labeling and advertisement of products
NAFDAC regulations on labeling state that labeling shall be informative and accurate.  The minimum information that 
must appear on the label are the name of product, full location address of the manufacturer, batch number, date of manufacture 
and best before date; net contents of essential ingredients in metric weight in case of solids, semi-solids and aerosols, and metric 
volume in case of liquids. In the case of food, the ingredients must be listed by their common names in order of their 
preponderance by weight unless the food is standardized. Food additives and colours must be declared on the label. Spices, 
flavour and colours may be listed as such, without naming the specific material, but any artificial colour or flavour must be 
identified as such. The label must contain directions for safe use where appropriate or necessary on the information panel or on 
the package insert.
Table 2: Medicinal plants’ products’ classification (Source: Authors’ computation from market survey data)
Classification Frequency Percent







Fertility drug 5 3.85
Sexual dysfunction remedies 14 10.77
Bronchia dilators 3 2.31
Expectorants 2 1.54
Hypoglycemic drugs 5 3.85
Vaccines 2 1.54





Adegboyega and Oluwalana  Afr J Tradit Complement Altern Med. (2011) 8(3):370‐376 374
When a food product is labelled with a claim of special dietary use, which includes claims of disease prevention, 
treatment, mitigation, cure or diagnosis, it must comply with the guidelines on drugs and registered as medicinal product.
Advertisements for regulated products are to be submitted to NAFDAC for vetting and approval. Only NAFDAC registered 
products can be advertised.  Documentation to be submitted to NAFDAC when seeking advertisement approval includes evidence 
of product registration, advertisement materials (television/radio script/storyboard, outdoor script/artwork, press script/artwork) 
and product samples in all pack sizes.
Discussion
Market structure and conduct
The prime movers of the formal medicinal plants’ products market in Nigeria were the entrepreneurs.  They were the 
active link between the traditional medicine and the medicinal plants’ products formal market. The advertising agents/media 
played the role of deepening the market. The extent to which the market existed in the consciousness of Nigerian consumers was 
the result of the various advertisements that were conveyed through the electronic media. NAFDAC, the legal regulator of the 
market, succeeded in exerting its authority in the market and ensuring the need for certification of the products was appreciated by 
the key participants.  The certification was also being used by some of the firms to adduce quality to their products in the course 
of marketing them. 
The market was young and small in size. Most of the products were new and yet to mature in terms of product life 
cycle. Thus, if properly nurtured through appropriate standardization and regulations, the market can grow and contribute to the 
supply of healthcare products in Nigeria. The market was found to be highly concentrated when assessed in terms of origin 
(local/imported) of products, market share by the sellers, mode of presentation of the product and the registration status of the 
products. High concentration of the market implies inadequate competition and limited opportunity for choices by the consumers 
(UNCTAD, 2002). Inadequate competition can adversely affect the development of the market.
The physical and the facilitating functions performed by some participants in the market played critical roles in 
establishing the formal market for medicinal plants’ products.  Processing of medicinal plants into acceptable forms such as 
capsules, tablets, etc and the mode of distribution made them generally more acceptable. Traditional medicine whose accumulated
knowledge has been feeding into the formal market for medicinal plants’ products (Odugbemi, 2007) is sometimes associated 
with witchcraft (Mafimisebi and Oguntade, 2010) thus limiting its acceptance. The physical and the facilitating functions being 
performed by the participants in the formal market are helping to translate the knowledge and products available in traditional 
medicine into forms that are more standardized, acceptable and accessible. The regulatory and standardization roles being 
performed by NAFDAC have increased the acceptability of medicinal plants’ products.  The aggressive pricing and promotional 
strategies adopted by the firms has helped to give visibility to the products and to gradually establish the small but growing 
market.
Standards and regulations governing the market
NAFDAC regulations cover registration of manufacturers, registration of products, labeling of products and 
advertisement of products. The regulations for the registration of manufacturers ensure that only body corporate and/or legal 
persons are permitted to manufacture or import regulated products, which include medicinal plants’ products that are traded in the 
formal markets in Nigeria.  This ensures accountability for culpable activities under the applicable laws of Nigeria.
The regulations for the registration of products are designed to ensure that products are distinctly identifiable and that 
only products that meet the required local and international quality standards are given certifications.  In this respect, laboratories 
set up by NAFDAC played a key role. The products must hence meet some minimum quality standards before being registered by 
NAFDAC.  The registration of most of the products under “Listing Status” subjects them to re-assessment every two years 
whereas “Full Registration Status” requires re-assessment only after every five years. This will increase the opportunity to re-
assess and monitor the products.
The labeling guidelines ensure that consumers of the products are provided as much information as necessary to clearly 
identify what they are consuming, know how to safely use the products and to identify the source of the products they are 
consuming.  The guidelines also provide a basis for following up on culpability when products are offered to consumers in 
contravention of the applicable local and international standards and regulations. The vetting of the advertisements of regulated 
products under the NAFDAC decrees is directed at ensuring that they are devoid of misleading information, half-truth, vague 
unsubstantiated statements, obnoxious and deceitful claims.  The vetting is also to ensure that the advertisements do not contain 
statements that can promote irrational drug therapy (usage) or statements that disparage competing products.  In general, these 
regulations have assisted in providing a standardized market framework which has increased the acceptability of medicinal plants’
products.
In spite of the current status of the market, standards and regulations for the formal market for medicinal plants’ 
products are still not fully developed.  It is being regulated by NAFDAC under the NAFDAC Decrees and Regulations, 1993 –
1999 which are designed to regulate food and drugs administration in general. The peculiarities of the young and developing 
medicinal plants’ products market may not have been adequately covered.  The issues that require specific regulatory attention 
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include sources and method of collection of the medicinal plants’ materials used in producing the products, the handling and 
mode of storage of the materials, etc which can affect the quality and efficacy of the final products (WHO, 2007).
In Canada, the Natural Health Product Regulations was put in place with effect from January 1, 2004 to regulate the 
medicinal plants’ products’ market. A specialized directorate, Natural Health Products Directorate, is responsible for 
administering the regulations. Previously, natural health products were classified as either foods or drugs under the Food and 
Drugs Act and Regulations.  The regulations include provisions for definitions, product licensing, site licensing, good 
manufacturing practices, clinical trials, and labeling and packaging requirements. (Agriculture and Agri-Foods Canada, 2009).  In 
the U.S., medicinal plants’ products’ market for humans is governed by the standards and regulations set by the Food and Drug 
Administration. Specifically, dietary supplements and phyto-pharmaceuticals are currently regulated under the US Dietary 
Supplement Health and Education Act, 1999. Dietary supplements are defined as "preparations that contain vitamins, minerals, 
and herbs which are used in addition to a normal “diet". While the Food and Drug Administration is responsible for regulation, 
the monitoring of advertising is the remit of the Food Trade Commission (Dvorkin, 2002).
The European Union is trying to establish common standards and regulations to govern the market.  The “Guideline on 
Good Agricultural and Collection Practice (GACP) for Starting Materials of Herbal Origin” was published in 2006. The guideline 
is to ensure consistent quality of the herbal substances that are used in the manufacture of medicinal plants’ products. The latest 
set of standards and regulations for the herbal products’ market were published on 1st September 2008 and took effect on 1st
September 2009 (European Commission, 2008). These relate to good manufacturing practice in respect of medicinal products 
which are meant for human and veterinary use. These efforts are being made given the special regulatory needs of the market.
Conclusion
We can clearly identify a small but growing formal market for medicinal plants’ products in Nigeria. Special pricing 
and promotional strategies were being used to market the products. The applicable laws subject the local production, importation, 
exportation, manufacture, advertisement, distribution, sale and use of medicinal plants’ products in Nigeria to NAFDAC standards 
and regulations. The application of these regulations has helped to create some confidence in the products being offered in the 
market. In spite of this, it is necessary to take another look at these standards and regulations as they affect medicinal plants’ 
products given the special regulatory needs of the market. The issues that should be considered for specific attention include 
sources and methods of collection of the medicinal plants’ materials used in producing the products, the handling and mode of 
storage of the materials, etc which can affect the quality and efficacy of the final products.
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